Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Arie P Dosoretz

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Advances in Radiation Oncology|September 30, 2022
Hazardous Attitudes: Physician Decision Making in Radiation OncologyNadia A Saeed, Adriana Blakaj, Jacqueline R Kelly, et al.
International Journal of Radiation Oncology, Biology, Physics|October 25, 2011
Predictive factors for radiation pneumonitis in Hodgkin lymphoma patients receiving combined-modality therapyAmy M Fox, Arie P Dosoretz, Peter M Mauch, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 22, 2019
Multi-institutional analysis of stereotactic body radiation therapy for operable early-stage non-small cell lung carcinomaBenjamin H Kann, Vivek Verma, John M Stahl, et al.
International Journal of Radiation Oncology, Biology, Physics|January 7, 2021
Drivers of Medicare Spending: A 15-Year Review of Radiation Oncology Charges Allowed by the Medicare Physician/Supplier Fee-for-Service Program Compared With Other SpecialtiesMeriem Mokhtech, James H Laird, Sean Maroongroge, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 5, 2018
Stereotactic body radiotherapy with adjuvant systemic therapy for early-stage non-small cell lung carcinoma: A multi-institutional analysisBenjamin H Kann, Joseph A Miccio, John M Stahl, et al.
International Journal of Radiation Oncology, Biology, Physics|November 22, 2016
The Effect of Biologically Effective Dose and Radiation Treatment Schedule on Overall Survival in Stage I Non-Small Cell Lung Cancer Patients Treated With Stereotactic Body Radiation TherapyJohn M Stahl, Rudi Ross, Eileen M Harder, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 29, 2016
Patient-reported quality of life after stereotactic body radiation therapy versus moderate hypofractionation for clinically localized prostate cancerSkyler Bryce Johnson, Pamela R Soulos, Timothy D Shafman, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Advances in Radiation Oncology|September 30, 2022
Hazardous Attitudes: Physician Decision Making in Radiation OncologyNadia A Saeed, Adriana Blakaj, Jacqueline R Kelly, et al.
International Journal of Radiation Oncology, Biology, Physics|October 25, 2011
Predictive factors for radiation pneumonitis in Hodgkin lymphoma patients receiving combined-modality therapyAmy M Fox, Arie P Dosoretz, Peter M Mauch, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 22, 2019
Multi-institutional analysis of stereotactic body radiation therapy for operable early-stage non-small cell lung carcinomaBenjamin H Kann, Vivek Verma, John M Stahl, et al.
International Journal of Radiation Oncology, Biology, Physics|January 7, 2021
Drivers of Medicare Spending: A 15-Year Review of Radiation Oncology Charges Allowed by the Medicare Physician/Supplier Fee-for-Service Program Compared With Other SpecialtiesMeriem Mokhtech, James H Laird, Sean Maroongroge, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 5, 2018
Stereotactic body radiotherapy with adjuvant systemic therapy for early-stage non-small cell lung carcinoma: A multi-institutional analysisBenjamin H Kann, Joseph A Miccio, John M Stahl, et al.
International Journal of Radiation Oncology, Biology, Physics|November 22, 2016
The Effect of Biologically Effective Dose and Radiation Treatment Schedule on Overall Survival in Stage I Non-Small Cell Lung Cancer Patients Treated With Stereotactic Body Radiation TherapyJohn M Stahl, Rudi Ross, Eileen M Harder, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 29, 2016
Patient-reported quality of life after stereotactic body radiation therapy versus moderate hypofractionation for clinically localized prostate cancerSkyler Bryce Johnson, Pamela R Soulos, Timothy D Shafman, et al.
Pageof 2